New Trial Looks at HIV’s Risks to Hearts of Aging Patients

South Africa is one of five countries to conduct the first major clinical trial that attempts to prevent heart disease and stroke among HIV-positive patients, who are at higher risk of these conditions. The Randomized Trial to Prevent Vascular Events in HIV, known as REPRIEVE, is enrolling participants in what is a new front in the war on AIDS, helping those living with the virus to lead long and healthy lives. The $20-million-a-year, U.S.-funded trial, which is expected to take about...

What feeling does this article give you?

#hashtags to follow:

South Africa [+]    HIV [+]    Randomized Trial [+]    Prevent Vascular Events [+]    REPRIEVE [+]   

More #news: